Anastrozole Tablets, USP, 1 mg, 1,000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534. NDC 68382-209-10
Published June 26, 2019 · Recall initiated: May 6, 2019
Summary
FDA records drug Class II recall D-1441-2019, published June 26, 2019 and initiated May 6, 2019. Recalling firm: Zydus Pharmaceuticals USA Inc; Status: Terminated; Reported quantity: 768 1000-count bottles; Lot: Lot EXP Date: M708570 Jun-19, M711270 Sep-19, M802207 Feb-20, M812460 Aug-20. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
What to do
Voluntary: Firm initiated · Letter
Get an email if ANASTROZOLE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ANASTROZOLE
- Manufacturer
- Zydus Pharmaceuticals USA Inc
- Distributor
- Nationwide in the USA
- Lot
- Lot EXP Date: M708570 Jun-19, M711270 Sep-19, M802207 Feb-20, M812460 Aug-20
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAnastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, RxJuly 17, 2019
- FDAAnastrozole Tablets, USP, 1mg, 30-count unit dose blisters per carton, Rx Only, Packaged and Distributed by:June 26, 2019
- FDARobafen DM, Generic for Robitussin DM, In each teaspoonful (5mL): Dextromethorphan HBr, USP 10mg,/Guaifenesin,June 26, 2019
- FDAPramipexole Dihydrochoride Tablets 0.25 mg, 90-count bottle, Rx Only, Manufactured by: Cadila Healthcare LtdJune 26, 2019
- FDACetirizine Oral Solution 1 mg/mL, Up & Up, Children's allergy relief, Antihistamine, Dye Free, Grape Flavor, 4June 26, 2019
- FDAPramipexole Dihydrochloride Tablets 0.5 mg, 90-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd.June 26, 2019
Questions about this recall
Was Anastrozole Tablets, USP, 1 mg, 1,000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534. NDC 68382-209-10 recalled?
Yes. FDA published recall D-1441-2019 on June 26, 2019. Reported hazard: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ANASTROZOLE.